Our Experience |
|
 |
IDEXX Laboratories (ticker IDXX) is a worldwide leader in the development and commercialization of innovative technology-based products and services for veterinary, food and water applications. With revenues of ~$1 billion, IDEXX conducts operations through more than 60 locations around the world, and employs nearly 5,000 people. David Shaw founded the company in 1983 and served as IDEXX’s CEO and chairman for more than 17 years. |
 |
Ikaria Holdings is a fully integrated critical care pharmaceutical company focusing on life saving drugs. The company employs more than 450 people. David Shaw served as the company’s founding CEO, and subsequently as Executive Chairman. Black Point Group was part of the investment syndicate that created the new company in 2007 via a $670 million cash and stock merger. |
 |
FetchDog is a Maine based catalog and website serving the needs of passionate dog owners. Black Point Group founded the company in 2007 and has provided active day-to-day management support since inception. David Shaw has previously served as CEO and Chairman of the company and now serves on the company's board of directors. Bill End and Ben Shaw have been operationally active in building the company. |
|
Direct Vet Marketing (dba Vets First Choice) is an emerging leading provider of ecommerce and marketing solutions for veterinary hospitals and pet owners aimed at the $6 billion market for veterinary medications and diets. The company offers pet owners a convenient online ordering and direct-to-home delivery service for veterinary medications and prescription diets from their trusted veterinarian at a competitive price. Black Point Group founded Direct Vet Marketing and Ben Shaw serves as CEO. |
 |
Ironwood Pharmaceuticals (formerly Microbia, Inc.) is an entrepreneurial pharmaceutical company dedicated to creating, developing and commercializing innovative human medicines. The company is advancing several clinical candidates including linaclotide, for gastrointestinal applications. Black Point Group has participated in Ironwood equity financing which has totaled nearly $300 million. David Shaw currently serves on the company’s board of directors. |
 |
Cytyc Corp. is a world-wide leader in women’s health, including novel products and technology for the detection of cervical cancer. The company was acquired by Hologic, Inc. in 2007 for $6.2 billion. David Shaw was a founding director and investor of Cytyc. |
 |
Sirna Therapeutics is a leader in creating RNAi-based therapies and leveraging the potential of this technology to ultimately treat patients. Black Point Group co-founded Skinetics Biosciences in 2004 to develop RNAi technologies in the dermatology market, and the company was subsequently acquired by Sirna. Merck & Co., Inc. acquired Sirna in 2006 for $1.1 billion. |
 |
Cornerstone Brands is an established leader in direct marketing of the finest home, leisure and casual brands including Frontgate, Garnet Hill, Ballard Designs and Smith & Noble. Cornerstone was co-founded by Bill End in 1995 and sold to IAC/InterActiveCorp. in 2004. Black Point Group was an investor in Cornerstone Brands. |
 |
Venrock is a leading venture capital firm with offices in New York, Palo Alto and Boston. Originally established as the venture capital arm of the Rockefeller family, Venrock continues an eight-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Black Point Group is a Venrock limited partner and David Shaw was a partner in the firm. |
